| 000 | 03968nam a2200289 i 4500 | ||
|---|---|---|---|
| 999 |
_c10525 _d10525 |
||
| 005 | 20201006122139.0 | ||
| 008 | 160214s2009 enka|||| |||| 00| 0 eng d | ||
| 020 | _a9780444532947 (hbk.) | ||
| 020 | _a0444532943 (hbk.) | ||
| 040 |
_aEG-NcFUE _erda |
||
| 082 | 0 | 4 |
_222 _a615.7042 _bS |
| 245 | 0 | 0 |
_aSide effects of drugs annual 31 : _b a worldwide yearly survey of new data and trends in adverse drug reactions and interactions / _cEditor J. K Aronson. |
| 264 | 1 |
_aAmsterdam ; _aLondon : _bElsevier Science, _c2009. |
|
| 300 |
_axli, 806 pages: _billustartions ; _c25 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 500 | _apharmacy bookfair2016 | ||
| 505 | 0 | _a Front cover; Side effects of drugs annual 31; Copyright page; Contents; Contributors; Special reviews; Cumulative indexes of special reviews, Annuals 12-30; Index of drugs; Index of adverse effects; Table of Essays, Annuals 1-30; Classifications of adverse drug reactions; 1. EIDOS; 2. DoTS; How to use this book; THE SCOPE OF THE ANNUAL; PERIOD COVERED; SELECTION OF MATERIAL; CLASSIFICATION OF DRUGS; DRUG NAMES; SYSTEM OF TAGGING REFERENCES; INDEXES; Side Effects of Drugs Essay: MedDRA®: the Tale of a Terminology; The history of MedDra; The scope and structure of MedDra Sustaining MedDra: the MSSO and Management BoardMedDra and regulatory agencies; Applications of MedDra: coding; Applications of MedDra: data retrieval and presentation; The future of MedDra; Conclusions; Acknowledgements; References; Chapter 1. Central nervous system stimulants and drugs that suppress appetite; AMPHETAMINES; Ecstasy (3,4-methylenedioxymetamfetamine, MDMA); Metamfetamine; Atomoxetine; Methylphenidate; Modafinil; METHYLXANTHINES; Caffeine; Theophylline; DRUGS THAT SUPPRESS APPETITE; Phentermine; Sibutramine; DRUGS USED IN ALZHEIMER'S DISEASE; Donepezil; Rivastigmine; REFERENCES Chapter 2. Antidepressant drugsGENERAL; SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRIs); SSRIs and suicide; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS (SNRIs); Venlafaxine; OTHER ANTIDEPRESSANTS; Bupropion (amfebutamone); Reboxetine; REFERENCES; Chapter 3. Lithium; REFERENCES; Chapter 4. Drugs of abuse; CANNABINOIDS; COCAINE; Ecstasy (3,4-methylenedioxymetamfetamine, MDMA); Khat; OPIOID ANALGESICS; REFERENCES; Chapter 5. Hypnosedatives and anxiolytics; BENZODIAZEPINES; Alprazolam; Diazepam; Flunitrazepam; Lorazepam; Midazolam; Quazepam; Temazepam; Triazolam; OTHER HYPNOSEDATIVES Chloral hydrateZolpidem; Zopiclone; REFERENCES; Chapter 6. Antipsychotic drugs; GENERAL; INDIVIDUAL DRUGS; Amisulpride; Clozapine; Haloperidol; Olanzapine; Quetiapine; Risperidone; Sarcosine; Ziprasidone; REFERENCES; Chapter 7. Antiepileptic drugs; GENERAL; Carbamazepine; Gabapentin; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenytoin and fosphenytoin; Pregabalin; Tiagabine; Topiramate; Valproate sodium and semisodium (divalproex); Vigabatrin; Zonisamide; REFERENCES; Chapter 8. Opioid analgesics and narcotic antagonists; GENERAL; OPIOID RECEPTOR AGONISTS; Alfentanil; Codeine DextromethorphanDextropropoxyphene; Diamorphine (heroin); Fentanyl; Frakefamide; Hydrocodone; Hydromorphone; Methadone; Morphine; Morphine-6-glucuronide; Oxycodone; Oxymorphone; Papaverine; Pethidine (meperidine); Remifentanil; Sufentanil; Tramadol; PARTIAL OPIOID RECEPTOR AGONISTS; Buprenorphine; Butorphanol; OPIOID RECEPTOR ANTAGONISTS; Naloxone; Naltrexone; REFERENCES; Chapter 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout; ANILINE DERIVATIVES; Paracetamol (acetaminophen) and combinations; NON-STEROIDAL ANTIINFLAMMATORY DRUGS; ARYLALKANOIC ACID DERIVATIVES | |
| 650 | 0 |
_aDrugs _xSide effects _vPeriodicals. |
|
| 650 | 0 |
_aPharmacology _vPeriodicals. |
|
| 650 | 0 | _aDrug interactions. | |
| 700 | 1 |
_aAronson, J. K. _eeditor. |
|
| 856 |
_3Abstract _uhttp://repository.fue.edu.eg/xmlui/handle/123456789/1835 |
||
| 942 |
_2ddc _cBK |
||